Want to join the conversation?
$ESRX's 3Q15 adjusted EBITDA increased 4% year-over-year as a result of managing specialty, formulary management and an increase in the aggregate generic fill rate. Adjusted SG&A expenses increased 2% year-over-year. Adjusted EBITDA per claim was $5.51, an increase of 4% year-over-year. $ESRX deployed approx. $1.2Bil of cash to repay debt in 3Q15.
$DB is going to cut off services for about 3,400 clients in equities trading.
$F stock slid more than 2% after the company issued two safety recalls involving more than 650,000 Ford Fusion and Lincoln MKZ model cars.
The new CEO of $SBUX, Kevin Johnson, has some pretty large shoes to fill but there are many who have good faith in his ability to do so.
$TSLA opening a showroom in Michigan. A bold move !!